首页 | 本学科首页   官方微博 | 高级检索  
检索        

参附脱毒胶囊Ⅱ期临床110例双盲评估研究
引用本文:张锐敏,李吉祥,孙新会,郑玲,杨丽萍,张杰,李建华,马克坚,袁小波,万文鹏.参附脱毒胶囊Ⅱ期临床110例双盲评估研究[J].中国药物依赖性杂志,2002,11(3):197-201,232.
作者姓名:张锐敏  李吉祥  孙新会  郑玲  杨丽萍  张杰  李建华  马克坚  袁小波  万文鹏
作者单位:云南省药物依赖防治研究所,昆明,650228
摘    要:目的··:评价参附脱毒胶囊用于阿片类依赖者脱毒治疗的疗效及不良反应。方法··:110例随机双盲对照试验设计 ,对照药为盐酸可乐定 ,其中参附脱毒胶囊组80例 ,可乐定组30例。结果··:参附脱毒胶囊控制戒断症状的作用与可乐定相同 (P>0.05) ,控制典型戒断症状 (如骨肌肉痛 )优于可乐定 (P<0.05)。结论··:参附脱毒胶囊用于阿片类依赖的脱毒治疗疗效肯定 ,安全可靠 ,无严重不良反应。

关 键 词:参附脱毒胶囊  可乐定  海洛因依赖  戒断症状  不良反应

A DOUBLE- BLIND CLINICAL TRIAL OF SHENGFUTUODU CAPSULE IN THE TREATMENT OF HEROIN WITHDRAWAL SYMPTOMS
Abstract:Objective: To evaluate the effect and safety of Shenfutuodu capsule, a traditional Chinese medicine, on alleviating opiate withdrawal symptoms in heroin addicts. Methods: A randomized, double-blind trial was carried out in 110 heroin addicts. They had been treated for 10 days. Results: In Shenfutudu group, the alleviation of withdrawal symptoms was similar to that in Clonidine group, and the effect of relieving pain was better than clonidine. Conclusion: Shenfutudu capsule is effective in the treatment of opiate withdrawal symptoms without serious side effects.
Keywords:
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号